Showing results (11-20 of 311) with videos related to
Sort By:
Pageof 32
Journal of Immunological Methods|August 15, 2015
Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluidNiels Kruse, Brit MollenhauerInternational Review of Neurobiology|May 31, 2017
Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's DiseaseIskandar Johar, Brit Mollenhauer, Dag AarslandScience (New York, N.Y.)|August 18, 2022
Toward preventing Parkinson's diseaseBrit Mollenhauer, Christine A F von ArnimMovement Disorders : Official Journal of the Movement Disorder Society|October 21, 2022
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's DiseaseMichael Bartl, Mohammed Dakna, Sebastian Schade, et al.Brain : a Journal of Neurology|July 26, 2022
CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathologyShay Herman, Ruth Djaldetti, Brit Mollenhauer, et al.Bioanalysis|May 16, 2017
Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluidNiels Kruse, Omar M El-Agnaf, Brit MollenhauerNPJ Parkinson'S Disease|May 17, 2024
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's diseaseMichael Bartl, Johanna Nilsson, Mohammed Dakna, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 24, 2011
Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routineFriederike Sixel-Döring, Marcus Schweitzer, Brit Mollenhauer, et al.Sleep|March 4, 2014
Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease?Friederike Sixel-Döring, Ellen Trautmann, Brit Mollenhauer, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 24, 2014
What can biomarkers tell us about cognition in Parkinson's disease?Brit Mollenhauer, Lynn Rochester, Alice Chen-Plotkin, et al.Pageof 32